{"status":"OK","data":{"advertisement":{"id":246479,"title":"Zapytanie ofertowe 29 03 2024 A (RFQ 29 03 2024 A)","partial_offer_allowed":false,"publication_date":"2024-04-02","submission_deadline":"2024-04-05 23:59:59","planned_sign_date":"2024-04-01","supplementary_orders":"Supplementary orders - the value of the changes (if necessary) will not exceed 50% of the contract value originally specified in the contract.","terms_of_contract_change":"The Ordering Party reserves the right to change the terms of the contract concluded as a result of these proceedings:\na. in the event of a change in applicable regulations, if it is necessary to adapt the content of the Agreement to the\ncurrent legal status (including applicable standards),\nb. where the need for amendment is a consequence of amendments to guidelines, recommendations or decisions\nissued by the institution which granted the appropriations to finance the Agreement,\nc. in the event of a change in the rate of tax on goods for the assortment being the subject of the Agreement,\nd. term of the contract \u2013 the Ordering Party reserves the right to change the expected date of the contract following\nchanges in the scope of the signed agreement for co-financing the Project(s) (extension of the duration of the\nProject(s) or relevant stages of the Project(s),\ne. order size \u2013 as a result of changes in the Project(s), the Ordering Party reserves the right not to complete the subject\nof the order in the full quantity estimated for purchase (Table above \u2013 column \"Estimated number of experiments\").\nThe minimum number of experiments that will be ordered is 1. The Contractor shall not be entitled to claim in this\nrespect;\nf. when the changes concern the provision of additional services not covered by the basic contract (supplementary\norders), the value of the changes will not exceed 50% of the contract value originally specified in the contract;\ng. unit prices of the subject of the contract - the Ordering Party allows a change in the amount of remuneration once\nfor each full calendar year of the duration of the Agreement (price indexation). For this purpose, the Contractor shall\npresent to the Ordering Party the Consumer Price Index published by the Central Statistical Office/Harmonized\nindices of consumer prices published by Eurostat for the period of the last 12 calendar months (\"Index\"). The salary\nincrease determined on the basis of the Index must be documented by the Contractor. Regardless of the level of the\nIndicator, the change may not exceed 10% year on year. The change requires at least documentary form. The\nindexed remuneration will be paid in the new amount starting from the first day of the following month after the\nchange in remuneration.4\nh. occurrence of force majeure - the Ordering Party reserves the right to change the terms of the contract concluded\nas a result of these proceedings also in the event of force majeure understood as an event that fundamentally\nhinders the performance of obligations under the co-financing agreement, which the parties could not foresee and\nprevent, as well as overcome through due diligence.\ni. in the case of conditions in accordance with Chapter 3.2.4. point 4 points b to e of the Guidelines on eligibility of\nexpenditure for the years 2021-2027","created_at":"2024-04-02 16:55:13","modified_at":"2024-04-06 00:00:03","contact_persons":[{"id":58,"forename":"Anna","surname":"Dziedzicka","phone_number":"+48 538 512 756","email":"vendors.clinical@ryvu.com","created_by":null,"created_at":"2025-07-31 13:43:16","modified_at":"2025-07-31 13:43:16","modified_by":null}],"orders":[{"id":399860,"estimated_value":null,"order_items":[{"id":450879,"description":"Human Cyclooxygenase (COX) enzyme inhibition assay carried out individually using recombinant COX 1 and COX 2 isoforms allowing estimation of inhibitory potency (IC50) using dose response of new chemical entity. Assay to be carried out using specific substrate for example arachidonic acid. Assay condition including standard inhibitors of each isoform as control validating the assay results.\n8 concentrations, 2 repetitions\n\nThe minimum estimated number of experiments each type to be performed during the contract term is 1.\nThe estimated number of experiments each type to be performed during the term of the contract is 6.\nOne experiment should be understood as an experiment performed on one compound.","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":null,"id":505624,"type":{"id":1,"name":"adres"},"group_uuid":"28987288-871d-413d-a702-91386977cae7"}],"participation_conditions":[{"id":1236051,"description":"Wymagania zamieszczono w za\u0142\u0105czonym Zapytaniu Ofertowym.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":null,"group_uuid":"c324317a-95bc-4e14-a1cf-abc071fb1fe6"},{"id":1236052,"description":"Uzupe\u0142niony Za\u0142\u0105cznik 1 (Appendix 1/Offer form).","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":null,"group_uuid":"ca06ee43-c7ff-4ac6-bd5d-954d873f1193"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":null,"group_uuid":"85d150be-f072-407d-a3cb-15b9cdcdf66e"}],"evaluation_criteria":[{"id":687702,"price_criterion":true,"description":"Cena 100%","created_by":null,"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":null,"group_uuid":"1647db11-9dfb-4db0-885a-9f12d790c2ee"}],"is_variant":false,"title":"Cz\u0119\u015b\u0107 1","order_node":{"id":303151},"created_by":null,"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":{"id":112,"contact_persons":[]},"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":{"id":112,"contact_persons":[]},"id":658950,"street":"Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2024-04-02 16:55:13","modified_at":"2024-04-02 16:55:13","modified_by":{"id":112,"contact_persons":[]},"id":247038},"advertisement":{"id":187383,"number":"2024-112-187383","publication_date":"2024-03-29","created_by":{"id":112,"contact_persons":[]},"created_at":"2024-03-29 14:35:14","modified_at":"2024-04-06 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[246385,246479],"enrollment":{"id":39917,"name":"Rozw\u00f3j celowanej terapii przeciwnowotworowej opartej o zahamowanie helikazy WRN (CanSL)","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-07-17 12:04:06","modified_at":"2023-07-17 12:04:06","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":246385,"publication_date":"2024-03-29"},"id":1277857,"name":"RFQ 29 03 2024 A","file":{"id":1424618,"name":"29 03 2024 A.pdf","created_at":"2024-04-02 16:55:13","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1424618"},"group_uuid":"3e2ad426-6501-47e6-b229-f9b3a57de60c"},{"origin":{"id":246385,"publication_date":"2024-03-29"},"id":1277858,"name":"Appendix 1 (Offer form to RFQ 29 03 2024 A)","file":{"id":1424619,"name":"Offer form to RFQ 29 03 2024 A (Appendix 1).docx","created_at":"2024-04-02 16:55:13","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1424619"},"group_uuid":"9b786676-4b6e-43f7-a26f-c4fd983f48ef"},{"origin":{"id":246479,"publication_date":"2024-04-02"},"id":1278901,"name":"Offer form to RFQ 29 03 2024 A (Appendix 1) - corrected","file":{"id":1425765,"name":"Offer form to RFQ 29 03 2024 A (Appendix 1) - corrected.docx","created_at":"2024-04-02 16:55:03","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1425765"},"group_uuid":"a31c2869-17b1-49e2-82a7-8b35b9571e48"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}